How to measure the impact of musculoskeletal conditions

Best Practice and Research: Clinical Rheumatology

Volumn 24, Issue 6, 2010, Pages 723-732

  Woolf, Anthony D ^a   Vos, Theo ^b   March, Lyn ^c  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; PRESCRIPTION DRUG; RHEUMATOID FACTOR;

CASE STUDY; COST OF ILLNESS; DISABILITY ADJUSTED LIFE YEAR; DISEASE MODEL; DISMOD GENERAL DISEASE MODEL; EPIDEMIOLOGICAL DATA; GOUT; HEALTH ADJUSTED LIFE EXPECTANCY; HEALTH CARE COST; HEALTH STATISTICS; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPERURICEMIA; INCIDENCE; INTERVIEW; JOINT RADIOGRAPHY; LIFE EXPECTANCY; MEASUREMENT; MEDICAL PRACTICE; MORTALITY; MUSCULOSKELETAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OSTEOARTHRITIS; OSTEOPOROSIS; PHYSICAL PARAMETERS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; RHEUMATOID ARTHRITIS; SOCIETY; THEORETICAL STUDY; WELLBEING;

COST OF ILLNESS; DISABLED PERSONS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MUSCULOSKELETAL DISEASES; PUBLIC HEALTH PRACTICE; QUALITY OF LIFE; SURVIVAL RATE;

EID: 79958791176     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2010.11.002     Document Type: Review

References (20)

1. Woolf AD, Akesson K. Understanding the burden of musculoskeletal conditions. The burden is huge and not reflected in national health priorities 4. BMJ 2001 May 5;322(7294):1079-80. (Pubitemid 32411177)
2. The Consensus Document. The bone and joint decade 2000-2010. Inaugural Meeting 17 and 18 April 1998. Acta Orthopaedica Scandinavica 1998;69(281):67-86.
3. Woolf AD. Economic burden of rheumatic diseases. In: Gary S, Firestein M, et al., editors. Kelley's Textbook of Rheumatology. 8th ed. Saunders, ISBN 978-1-4160-4842-8; 2008.
4. Lapsley HM, March LM, Tribe KL, Cross MJ, Brooks PM. Living with osteoarthritis: patient expenditures, health status, and social impact. Arthritis and rheumatism 2001 Jun;45(3):301-6. (Pubitemid 32952912)
5. Lapsley HM, March LM, Tribe KL, Cross MJ, Courtenay BG, Brooks PM. Living with rheumatoid arthritis: expenditures, health status, and social impact on patients. Annals of the Rheumatic Diseases 2002 Sep;61(9):818-21.
6. Woolf AD. The bone and joint decade 2000-2010. Annals of the Rheumatic Diseases 2000 Feb;59(2):81-2.
7. Molla MT, Madans JH, Wagener DK, Crimmins EM. Summary measures of population health: report of findings on methodologic and data issues. Hyattsville, Maryland: National Center for Health Statistics; 2003. DHHS Publication No. (PHS) 2004-1258. 2003.
8. The Global Burden of Disease. A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 (Global Burden of Disease and Injury Series, Vol. 1). Cambridge M.A., USA: Harvard University Press; 1996.
9. World Development Report 1993. World Bank. Oxford University Press, ISBN 0-19-520889-7; 1993.
10. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bulletin of the World Health Organization 1994;72(3):429-45. (Pubitemid 24234133)
11. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Population Health Metrics 2003 Apr 14;1(1):4.
12. WHO International Classification of functioning, disability and health available at URL: http://www3.who.int/icf/icftemplate.cfm. WHO ICF Database 2007Available from: URL: http://www3.who.int/icf/icftemplate.cfm
13. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009 Feb 4;301(5):513-21.
14. Laakso M, Isomaki H, Mutru O, Koota K. Death certificate and mortality in rheumatoid arthritis. Scandinavian Journal of Rheumatology 1986;15(2):129-33. (Pubitemid 16048712)
15. Wicks IP, Moore J, Fleming A. Australian mortality statistics for rheumatoid arthritis 1950-81: analysis of death certificate data. Annals of the Rheumatic Diseases 1988 Jul;47(7):563-9.
16. The Burden of Musculoskeletal Diseases at the Start of the New Millenium. Report of a WHO Scientific group. Geneva, Switzerland: World Health Organization. TRS 919. Available at URL: http://whqlibdoc.who.int/trs/WHO-TRS- 919.pdf; 2003. Report No.: 919.
17. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financing Review 1985;7:61-80. (Pubitemid 17008319)
18. Pritchard C, Sculpher M. Productivity costs: principles and practice in economic evaluation. OHE; 2002.
19. Drummond M, Maetzel A, Gabriel S, March L. Towards a reference case for use in future economic evaluations of interventions in osteoarthritis. The Journal of Rheumatology. Supplement 2003 Dec;68:26-30. (Pubitemid 37549319)
20. Merkesdal S, Ruof J, Huelsemann JL, Schoeffski O, Maetzel A, Mau W, et al. Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis. The Journal of Rheumatology 2001 Mar;28(3):657-61. (Pubitemid 32202679)